Inactief instrument

Andere talen Elan Corporation Ltd Nyse

Aandelen

US2841312083

slotkoers Nyse Andere beurzen
- ^USD	-

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Paris repart en guerre contre Airbnb, avec une assignation en justice	10-02-19
Paris repart en guerre contre Airbnb avec une assignation en justice	10-02-19
Horizon Pharma Inc : With eye on tax rates, Horizon Pharma buys Ireland's Vidara	19-03-14
Elan Corporation, plc : Ex-SAC manager Martoma fails to end part of insider case	18-12-13
Elan Corporation, plc : Perrigo Company and Elan Corporation Plc Receive Irish High Court Approval for Perrigo’s Proposed Acquisition of Elan	13-12-13
Pfizer Inc. : Ex-SAC trader points to Cohen testimony in insider trading case	07-12-13
Elan Corporation, plc : Elan Announces Shareholder Approval of its Acquisition by Perrigo Company	18-11-13
Elan Corporation, plc : Elan wins shareholder approval to complete Perrigo sale	18-11-13
Elan Corporation, plc : The prosecutors with SAC Capital in their crosshairs	17-11-13
Elan Corporation, plc : Elan Reports Third Quarter 2013 Financial Results	24-10-13
Elan Corporation, plc : Exclusive - TPG-backed Aptalis Pharma hires banks for an IPO: sources	23-10-13
Elan Corporation, plc : Elan Announces Webcast of Third Quarter 2013 Financial Results	10-10-13
Elan Corporation, plc : Elan Announces Dates of Shareholder Meetings in Connection with Scheme of Arrangement	30-09-13
Bank of America Corp : Insider trading trial of SAC's Martoma delayed to January	25-09-13
Pfizer Inc. : Insider trading trial of SAC's Martoma delayed until January	24-09-13
Elan Corporation, plc : Elan Announces Dosing of First Patient in Phase 2a Trial of ELND005 (Scyllo-inositol) in Down Syndrome	03-09-13
Elan Corporation, plc : Perrigo Files Registration Statement on Form S-4 in Connection with Proposed Acquisition of Elan	28-08-13
Elan Corporation, plc : New Martoma indictment describes second doctor as insider source	23-08-13
Perrigo Company : Exclusive - TPG explores $3 billion sale of specialty drugmaker Aptalis	08-08-13
Actavis Inc : Exclusive: TPG explores $3 billion sale of specialty drugmaker Aptalis	07-08-13

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Elan Corporation Ltd Nyse

Aandelen

US2841312083

Andere talen

Filters